SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
Company Search   Charts   Research   Earnings   Ratings   Shareholders

Company Web Site

$123 million Market Cap at May 15, 2024
Biomedics SubIndustry up .00% / Health Industry up .00% Today
542 Flynn Road Research Report
Camarillo, CA 93012 Fact Sheet
Phone: (805) 987-0086 Financial Statements
Fax: (805) 987-3385 Peer Comparison
Annual Reports

J-P L. Conte, Interim Chmn., Terrance J. Bieker, Pres./CEO, Alan I. Edrick, CFO
Acquired by INVITROGEN CORP (Q:IVGN) October 6, 2005. Holders received $12.50 cash per share. Engages in the licensing, development, marketing and distribution of immunological reagents and Enzyme-Linked Immunsorbent Assay (ELISA) test kits used in biomedical research.

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $0

A1253
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex